As on Wednesday, Applied Therapeutics Inc (NASDAQ: APLT) started slowly as it slid -4.73% to $0.52, before settling in for the price of $0.55 at the close. Taking a more long-term approach, APLT posted a 52-week range of $0.43-$10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -8.72%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 6.97%. This publicly-traded company’s shares outstanding now amounts to $116.36 million, simultaneously with a float of $92.20 million. The organization now has a market capitalization sitting at $60.88 million. At the time of writing, stock’s 50-day Moving Average stood at $0.5634, while the 200-day Moving Average is $4.4184.
Applied Therapeutics Inc (APLT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Applied Therapeutics Inc’s current insider ownership accounts for 20.76%, in contrast to 84.07% institutional ownership. According to the most recent insider trade that took place on Mar 04 ’25, this organization’s Chief Medical Officer sold 10,366 shares at the rate of 0.44, making the entire transaction reach 4,561 in total value, affecting insider ownership by 890,409. Preceding that transaction, on Mar 04 ’25, Company’s insider sold 14,502 for 0.44, making the whole transaction’s value amount to 6,381. This particular insider is now the holder of 390,459 in total.
Applied Therapeutics Inc (APLT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
Applied Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 6.97% and is forecasted to reach -0.59 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 32.27% through the next 5 years, which can be compared against the -8.72% growth it accomplished over the previous five years trading on the market.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Let’s observe the current performance indicators for Applied Therapeutics Inc (APLT). It’s Quick Ratio in the last reported quarter now stands at 1.06. The Stock has managed to achieve an average true range (ATR) of 0.06.
Technical Analysis of Applied Therapeutics Inc (APLT)
Through scrutinizing the latest numbers posted by the [Applied Therapeutics Inc, APLT], it can be observed that its last 5-days Average volume of 1.77 million was lower the volume of 3.67 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 43.93% While, its Average True Range was 0.0570.
Raw Stochastic average of Applied Therapeutics Inc (APLT) in the period of the previous 100 days is set at 0.89%, which indicates a major fall in contrast to 28.55% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 108.55% that was lower than 243.99% volatility it exhibited in the past 100-days period.
